Drug
Valine
Valine is a pharmaceutical drug with 4 clinical trials. Currently 1 active trials ongoing.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Active Trials
1(25%)
Phase Distribution
Ph not_applicable
2
50%
Ph early_phase_1
2
50%
Phase Distribution
2
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution4 total trials
Early Phase 1First-in-human
2(50.0%)
N/ANon-phased studies
2(50.0%)
Highest Phase Reached
Early Phase 1Trial Status & Enrollment
Completion Rate
0.0%
0 of 1 finished
Non-Completion Rate
100.0%
1 ended early
Currently Active
1
trials recruiting
Total Trials
4
all time
Status Distribution
Active(2)
Terminated(1)
Other(1)
Detailed Status
Recruiting1
Withdrawn1
unknown1
Not yet recruiting1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
1
Success Rate
N/A
Most Advanced
Early Phase 1
Trials by Phase
Early Phase 12 (50.0%)
N/A2 (50.0%)
Trials by Status
recruiting125%
withdrawn125%
unknown125%
not_yet_recruiting125%
Recent Activity
1 active trials
Showing 4 of 4
not_yet_recruitingearly_phase_1
Sarcopenia in Chronic Kidney Disease (CKD) Patients
NCT07437053
recruitingearly_phase_1
Oral Intradialytic Amino Acid Supplementation to Vitalize End-stage Kidney Disease Patients on Hemodialysis
NCT05705414
unknownnot_applicable
Effects of Dietary Amino Acids on Serum and Macrophage Atherogenicity
NCT03180775
withdrawnnot_applicable
Amino Acid Supplementation in Recovery From Traumatic Brain Injury
NCT01495871
Clinical Trials (4)
Showing 4 of 4 trials
NCT07437053Early Phase 1
Sarcopenia in Chronic Kidney Disease (CKD) Patients
NCT05705414Early Phase 1
Oral Intradialytic Amino Acid Supplementation to Vitalize End-stage Kidney Disease Patients on Hemodialysis
NCT03180775Not Applicable
Effects of Dietary Amino Acids on Serum and Macrophage Atherogenicity
NCT01495871Not Applicable
Amino Acid Supplementation in Recovery From Traumatic Brain Injury
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4